FDA Approves Ozempic for Chronic Kidney Disease

(Dreamstime)

Tuesday, 28 January 2025 02:49 PM EST ET

Novo Nordisk said on Tuesday the U.S. FDA has approved its diabetes drug Ozempic to reduce the risk of worsening kidney disease and death due to cardiovascular disease in adults with Type 2 diabetes and chronic kidney disease. 

© 2025 Thomson/Reuters. All rights reserved.


Health-News
Novo Nordisk said on Tuesday the U.S. FDA has approved its diabetes drug Ozempic to reduce the risk of worsening kidney disease and death due to cardiovascular disease in adults with Type 2 diabetes and chronic kidney disease....
fda, ozempic, novo nordisk, kidney disease, chronic, cardiovascular, deaths
38
2025-49-28
Tuesday, 28 January 2025 02:49 PM
Newsmax Media, Inc.
Newsmax Media, Inc.

View on Newsmax